Regulus Therapeutics Inc (NASDAQ:RGLS)

1.23
Delayed Data
As of 4:00pm ET
 +0.03 / +2.50%
Today’s Change
0.79
Today|||52-Week Range
1.95
+18.27%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 1.75, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a +42.28% increase from the last price of 1.23.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Regulus Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$1.5M
Reporting Date
Feb 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.91%
 
 
 
 
 
 
Growthannually 37.42%
 
 
 
 
 
 

Sales

Growthquarterly 8,081.50%
 
 
 
 
 
 
Growthannually -36.82%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.